Modulation of canonical Wnt signaling by the extracellular matrix component biglycan

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 41, 2011, Pages 17022-17027

  Berendsen, Agnes D ^a   Fisher, Larry W ^a   Kilts, Tina M ^a   Owens, Rick T ^b   Robey, Pamela G ^a   Gutkind, J Silvio ^a   Younga, Marian F ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b LIFECELL CORPORATION   (United States)

Author keywords

Mineralization; Regeneration; Skeleton

Indexed keywords

BETA CATENIN; BIGLYCAN; CALCIUM; DICKKOPF 1 PROTEIN; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PROTEOGLYCAN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR RUNX2; WNT1 PROTEIN; WNT3A PROTEIN;

ADOLESCENT; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CALVARIA; CELL ACTIVITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FRACTURE HEALING; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VIVO STUDY; MICROENVIRONMENT; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BETA CATENIN; BIGLYCAN; EXTRACELLULAR MATRIX; HEK293 CELLS; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MICE; MICE, KNOCKOUT; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SKULL; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 80054754245     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1110629108     Document Type: Article

References (38)

1. MacDonald BT, Tamai K, He X (2009) Wnt/β-catenin signaling: Components, mechanisms, and diseases. Dev Cell 17:9-26.
2. Bienz M, Clevers H (2000) Linking colorectal cancer to Wnt signaling. Cell 103: 311-320.
3. Patel MS, Karsenty G (2002) Regulation of bone formation and vision by LRP5. N Engl J Med 346:1572-1574. (Pubitemid 34755698)
4. Lin X (2004) Functions of heparan sulfate proteoglycans in cell signaling during development. Development 131:6009-6021.
5. Ai X, et al. (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 162:341-351. (Pubitemid 36928846)
6. Colombres M, et al. (2008) Heparin activates Wnt signaling for neuronal morphogenesis. J Cell Physiol 216:805-815.
7. Ling L, et al. (2010) Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3-kinase/Akt/RUNX2 pathway. J Biol Chem 285:26233-26244.
8. Capurro MI, Xiang YY, Lobe C, Filmus J (2005) Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonicalWnt signaling. Cancer Res 65:6245-6254. (Pubitemid 40994410)
9. Alexander CM, et al. (2000) Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 25:329-332. (Pubitemid 30437323)
10. Williams BO, Insogna KL (2009) Where Wnts went: The exploding field of Lrp5 and Lrp6 signaling in bone. J Bone Miner Res 24:171-178.
11. Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434:843-850. (Pubitemid 40558990)
12. Kato M, et al. (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314. (Pubitemid 34839826)
13. Bodine PV, et al. (2004) The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice.Mol Endocrinol 18:1222-1237. (Pubitemid 38591287)
14. Glass DA, 2nd, et al. (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751-764.
15. Fisher LW, Termine JD, Young MF (1989) Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576. (Pubitemid 19081361)
16. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG (1990) Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 38:1549-1563. (Pubitemid 20346965)
17. Xu T, et al. (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20:78-82. (Pubitemid 28410350)
18. Papp C, et al. (2006) Prenatal diagnosis of Turner syndrome: Report on 69 cases. J Ultrasound Med 25:711-717. (Pubitemid 43830460)
19. Chen XD, Shi S, Xu T, Robey PG, Young MF (2002) Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res 17:331-340. (Pubitemid 34087666)
20. Chen XD, Fisher LW, Robey PG, Young MF (2004) The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J 18:948-958. (Pubitemid 38787591)
21. Shimizu H, et al. (1997) Transformation by Wnt family proteins correlates with regulation of β-catenin. Cell Growth Differ 8:1349-1358. (Pubitemid 28008731)
22. Liu G, Bafico A, Harris VK, Aaronson SA (2003) A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. Mol Cell Biol 23:5825-5835. (Pubitemid 36951344)
23. Wolf J, Palmby TR, Gavard J, Williams BO, Gutkind JS (2008) Multiple PPPS/TP motifs act in a combinatorial fashion to transduce Wnt signaling through LRP6. FEBS Lett 582:255-261.
24. Nelson WJ, Nusse R (2004) Convergence of Wnt, β-catenin, and cadherin pathways. Science 303:1483-1487. (Pubitemid 38314410)
25. Hocking AM, Strugnell RA, Ramamurthy P, McQuillan DJ (1996) Eukaryotic expression of recombinant biglycan: Post-translational processing and the importance of secondary structure for biological activity. J Biol Chem 271:19571-19577. (Pubitemid 26271635)
26. Xu Q, et al. (2004) Vascular development in the retina and inner ear: Control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116:883-895. (Pubitemid 38410732)
27. Semënov MV, et al. (2001) Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol 11:951-961.
28. Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455-8459. (Pubitemid 26269579)
29. Mani A, et al. (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315:1278-1282. (Pubitemid 46364265)
30. Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ (2000) WISP-1 is a Wnt-1- and β-catenin-responsive oncogene. Genes Dev 14:585-595.
31. French DM, et al. (2004) WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol 165:855-867. (Pubitemid 39129293)
32. Wegrowski Y, Pillarisetti J, Danielson KG, Suzuki S, Iozzo RV (1995) The murine biglycan: Complete cDNA cloning, genomic organization, promoter function, and expression. Genomics 30:8-17.
33. Ohkawara B, Yamamoto TS, Tada M, Ueno N (2003) Role of glypican 4 in the regulation of convergent extension movements during gastrulation in Xenopus laevis. Development 130:2129-2138. (Pubitemid 36656709)
34. De Cat B, et al. (2003) Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements. J Cell Biol 163:625-635. (Pubitemid 37429874)
35. Goldoni S, et al. (2009) Decorin is a novel antagonistic ligand of the Met receptor. J Cell Biol 185:743-754.
36. Amenta AR, et al. (2011) Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci USA 108:762-767.
37. Liu W, et al. (2008) Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance. Circ Res 103:1280-1288.
38. Keramati AR, et al. (2011) Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases, PDGF-dependent vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 108:1914-1918.